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It remains great uncertainties as to the safety of Genetically Modified 
Products (GM Products) derived from modern biotechnology, so while we 
happily enjoy the benefits of GM Products, how to avoid the potential risks 
caused by GM Products is also a problem well worth our observations. 
Currently, the vast majority of the countries in the world adopt the 
safety legislations on GM Products based on the process oriented approach 
in line with the Cartagena Protocol on Biosafety, and this approach is 
contradictive with the product oriented approach upon which the safety 
legislations on GM Products in only a few countries and the WTO rules on 
trade in goods are based. The highlight of this contradiction is between the 
precautionary principle embodied in the Biosafety Protocol and the principle 
of scientific evidence adopted by the WTO rules. As the largest trade bodies 
in the world, the United States of America and the European Communities 
adopt the above contradictive approaches on biosafety legislations 
respectively. With the US bringing the EC’s process oriented legislation to 
the WTO, it seems that the WTO dispute settlement body will have to be the 
ultimate arbiter on which approach is more suitable for the safety 
legislations on GM Products. 
    However, based upon past experiences and the characteristics of the 
ongoing WTO case, the author of this dissertation believes that the WTO 
dispute settlement body can not thoroughly resolve the dispute between the 
US and EC very effectively. In the area of GM Products whose safety 














live up to the expectations of the member countries to establish the highest 
safety standards in the areas of consumer protection and environment 
protection. The US-EC dispute should be a turning point in pushing the 
WTO rules to be readjusted so that it can accommodate the process oriented 
approach. 
Finally this dissertation makes several suggestions on how to 
harmonize the two contradictive approaches, and introduces the Chinese 
stand on this problem and some related issues needed to be noticed. 
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术（recombinant DNA technology）以及基因工程（genetic engineering）
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分的角度来看，如果产品含有转基因成分（containing or consisting of 
GMOs），我们一般称其为含有转基因成分的产品；如果产品本身或产
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许多加工产品中，我们习惯于称其为转基因成分。单词“organism”除
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